SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    King SB, Smith SC, Hirshfeld JW, Jacobs AK, Morrison DA, Williams DO. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol 2008; 51: 172209.
  • 2
    Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization. J Am Coll Cardiol 2009; 53: 530553.
  • 3
    Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SC Jr. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on the management of patients with chronic stable angina). J Am Coll Cardiol 2003; 41: 159168.
  • 4
    Kesani M, Aronow WS, Weiss MB. Prevalence of multivessel coronary artery disease in patients with diabetes mellitus plus hypothyroidism, in patients with diabetes mellitus without hypothyroidism, and in patients with no diabetes mellitus or hypothyroidism. J Gerontol A Biol Sci Med Sci 2003; 58: M857M858.
  • 5
    Hilliard AA, From AM, Lennon RJ, Singh M, Lerman A, Gersh BJ, Holmes DR, Rihal CS, Prasas A. Percutaneous revascularization for stable coronary artery disease. JACC Cardiovasc Interv 2010; 3: 172179.
  • 6
    Curtis JP, Schreiner G, Wang Y, Chen J, Spertus JA, Rumsfeld JS, Brindis RG, Krumholz HM. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients. J Am Coll Cardiol 2009; 54: 903907.
  • 7
    Hannan EL, Samadashvili Z, Walford G, Holmes DR Jr, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, King SB 3rd., Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv 2010; 3: 2231.
  • 8
    Barringhaus KG, Park KL, McManus DD, Steg PG, Montalescot G, Van de Werf F, López-Sendón J, FitzGerald G, Gore JM. Outcomes from patients with multi-vessel disease following primary PCI: Staged PCI imparts very low mortality. Cathet Cardiovasc Intervent 2011; 77: 617622.
  • 9
    Dangas GD, George JC, Weintraub W, Popma JJ. Timing of staged percutaneous interventnion in multivessel coronary artery disease. JACC Cardiovasc Interv 2010; 3: 10961099.
  • 10
    Salvati EA, Hughes P, Lachiewicz P. Bilateral total hip-replacement arthroplasty in one stage. J Bone Joint Surg Am 1978; 60: 640644.
  • 11
    Bhan S, Pankaj A, Malhotra R. One- or two-stage bilateral total hip arthroplasty: A prospective, randomised, controlled study in an Asian population. J Bone Joint Surg Br 2006; 88: 298303.
  • 12
    Soudry M, Binazzi R, Insall JN, Nordstrom TJ, Pellicci PM, Goulet JA. Successive bilateral total knee replacement. J Bone Joint Surg Am 1985; 67: 573576.
  • 13
    Hazelrigg SR, Boley TM, Magee MJ, Lawyer CH, Henkle JQ. Comparison of staged thoracoscopy and median sternotomy for lung volume reduction. Ann Thorac Surg 1998; 66: 11341139.
  • 14
    Barrett J, Baron JA, Losina E, Wright J, Mahomed NN, Katz JN. Bilateral total knee replacement: Staging and pulmonary embolism. J Bone Joint Surg Am 2006; 88: 21462151.
  • 15
    Eagle K, Guyton R, Davidoff R, Edwards F, Ewy G, Gardner T, Hart J, Herrmann H, Hillis L, Hutter A, Lytle B, Marlow R, Nugent W, Orszulak T, Antman E, Smith S, Alpert J, Anderson J, Faxon D, Fuster V, Gibbons R, Gregoratos G, Halperin J, Hiratzka L, Hunt S, Jacobs A, Ornato J. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 2004; 44: e213e310.
  • 16
    Smith S, Feldman T, Hirshfeld J, Jacobs A, Kern M, King S, Morrison D, O'Neill W, Schaff H, Whitlow P, Williams D, Antman E, Adams C, Anderson J, Faxon D, Fuster V, Halperin J, Hiratzka L, Hunt S, Nishimura R. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006; 47: e1e121.
  • 17
    Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL. Guidelines on the management of stable angina pectoris: Executive summary: The task force on the management of stable angina pectoris of the European society of cardiology. Eur Heart J 2006; 27: 13411381.
  • 18
    Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804847.
  • 19
    Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 54: 22052241.
  • 20
    Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58. (in press)
  • 21
    Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 1992; 326: 1016.
  • 22
    RITA-2 Trial Participants. Coronary angioplasty versus medical therapy for angina: The second randomised intervention treatment of angina (RITA-2) trial. Lancet 1997; 350: 461468.
  • 23
    Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: Outcomes for patients with double-vessel versus single-vessel coronary artery disease in a veterans affairs cooperative randomized trial. Veterans affairs ACME investigators. J Am Coll Cardiol 1997; 29: 15051511.
  • 24
    Pitt B, Waters D, Brown W, van Boven A, Schwartz L, Title L, Eisenberg D, Shurzinske L, McCormick L. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus revascularization treatment investigators. N Engl J Med 1999; 341: 7076.
  • 25
    Boden W, O'Rourke R, Teo K, Hartigan P, Maron D, Kostuk W, Knudtson M, Dada M, Casperson P, Harris C, Spertus J, Shaw L, Chaitman B, Mancini G, Berman D, Gau G, Weintraub W. The evolving pattern of symptomatic coronary artery disease in the United States and Canada: Baseline characteristics of the clinical outcomes utilizing revascularization and aggressive DruG evaluation (COURAGE) trial. Am J Cardiol 2007; 99: 208212.
  • 26
    Whalen RE, Harrell FE Jr, Lee KL, Rosati RA. Survival of coronary artery disease patients with stable pain and normal left ventricular function treated medically or surgically at Duke University. Circulation 1982; 65: 4952.
  • 27
    King S, Lembo N, Weintraub W, Kosinski A, Barnhart H, Kutner M, Alazraki N, Guyton R, Zhao X. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory angioplasty versus surgery trial (EAST). N Engl J Med 1994; 331: 10441050.
  • 28
    CABRI Trial Participants. First-year results of CABRI (coronary angioplasty versus bypass revascularisation investigation). Lancet 1995; 346: 11791184.
  • 29
    Rodriguez A, Mele E, Peyregne E, Bullon F, Perez-Baliño N, Liprandi MI, Palacios IF. Three-year follow-up of the Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI). J Am Coll Cardiol 1996; 27: 11781184.
  • 30
    Carrié D, Elbaz M, Puel J, Fourcade J, Karouny E, Fournial G, Galinier M. Five-year outcome after coronary angioplasty versus bypass surgery in multivessel coronary artery disease: Results from the French Monocentric Study. Circulation 1997; 96: II1II6.
  • 31
    The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Seven-year outcome in the bypass angioplasty revascularization investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000; 35: 11221129.
  • 32
    Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfield L, Martinez J, Vogel D, Grinfield R, Delacasa A, Garrido M, Oliveri R, Mele E, Palacios I, O'Neill W. Argentine randomized study: Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-Day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol 2001; 37: 5158.
  • 33
    Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LAC, Jatne FB, Oliveira SA, Ramires JAF. Five-year follow-up of the medicine, angioplasty, or surgery study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115: 10821089.
  • 34
    Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER, Lilly RE, Sketch MH Jr, Peterson ED, Jones RH. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg 2006; 82: 14201428.
  • 35
    Bair TL, Muhlestein JB, May HT, Meredith KG, Horne BD, Pearson RR, Li Q, Jensen KR, Anderson JL, Lappe DL. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: Results from the Intermountain Heart Registry. Circulation 2007; 116: I226I231.
  • 36
    Dacey LJ, Likosky DS, Ryan TJ Jr, Robb JF, Quinn RD, DeVries JT, Hearne MJ, Leavitt BJ, Dunton RF, Clough RA, Sisto D, Ross CS, Olmstead EM, O'Connor GT, Malenka DJ. Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease. Ann Thorac Surg 2007; 84: 19041911.
  • 37
    Leape LL, Park RE, Bashore TM, Harrison JK, Davidson CJ, Brook RH. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. Am Heart J 2000; 139: 106113.
  • 38
    Fisher LD, Judkins MP, Lesperance J, Cameron A, Swaye P, Ryan T, Maynard C, Bourassa M, Kennedy JW, Gosselin A, Kemp H, Faxon D, Wexler L, Davis KB. Reproducibility of coronary arteriographic reading in the coronary artery surgery study (CASS). Cathet Cardiovasc Diagn 1982; 8: 565575.
  • 39
    Lavi S, Rihal CS, Yang EH, Fassa AA, Elesber A, Lennon RJ, Mathew V, David HR Jr, Lerman A. The effect of drug eluting stents on cardiovascular events in patients with intermediate lesions and borderline fractional flow reserve. Catheter Cardiovasc Interv 2007; 70: 525531.
  • 40
    Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech J, van't Veer M, Bär F, Hoorntje J, Koolen J, Wijns W, de Bruyne B. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-Year follow-up of the DEFER Study. J Am Coll Cardiol 2007; 49: 21052111.
  • 41
    Pijls NHJ, Fearon WF, Tonino PAL, Siebert U, Ikeno F, Bornschein B, van't Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, De Bruyne B. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel cornary artery disease. J Am Coll Cardiol 2010; 56: 177184.
  • 42
    Christou M, Siontis G, Katritsis D, Ioannidis J. Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. Am J Cardiol 2007; 99: 450456.
  • 43
    Costa MA, Sabate M, Staico R, Alfonso F, Seixas AC, Albertal M, Crossman A, Angiolillo DJ, Zenni M, Sousa JE, Macaya C, Bass TA. Anatomical and physiologic assessments in patients with small coronary artery disease: Final results of the physiologic and anatomical evaluation prior to and after stent implantation in small coronary vessels (PHANTOM) trial. Am Heart J 2007; 153: 296297.
  • 44
    Tonino P, De Bruyne B, Pijls N, Siebert U, Ikeno F, van't Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd K, Ver Lee P, MacCarthy P, Fearon W. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360: 213224.
  • 45
    Melikian N, De Bondt P, Tonino P, De Winter O, Wyffels E, Bartunek J, Heyndrickx GR, Fearon WF, Pijls NHJ, Wijns W, De Bruyne B. Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. JACC Cardiovasc Interv 2010; 3: 307314.
  • 46
    Kobori Y, Tanaka N, Takazawa K, Yamashina A. Usefulness of fractional flow reserve in determining the indication of target lesion revascularization. Catheter Crdiovasc Intervent 2005; 65: 355360.
  • 47
    Caymaz O, Fak AS, Tezcan H, Inanir SS, Toprak A, Tokay S, Turoglu T, Oktay A. Correlation of myocardial fractional flow reserve with thallium-201 SPECT imaging in intermediate-severity coronary artery lesions. J Invasive Cardiol 2000; 12: 345350.
  • 48
    Yanagisawa H, Chikamori T, Tanaka N, Hatano T, Morishima T, Hida S, Iino H, Amaya K, Takazawa K, Yamashina A. Correlation between thallium-201 myocardial perfusion defects and the functional severity of coronary artery stenosis as assessed by pressure-derived myocardial fractional flow reserve. Circ J 2002; 66: 11051109.
  • 49
    Yanagisawa H, Chikamori T, Tanaka N, Usui Y, Takazawa K, Yamashina A. Application of pressure-derived myocardial fractional flow reserve in assessing the functional severity of coronary artery stenosis in patients with diabetes mellitus. Circ J 2004; 68: 993998.
  • 50
    Courtis J, Rodés-Cabau J, Larose E, Déry JP, Nguyen CM, Proulx G, Gleeton O, Roy L, Barbeau G, Noël B, DeLarochellière R, Bertrand OF. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements. Cathet Cardiovasc Intervent 2008; 71: 541548.
  • 51
    Bech GJ, De Bruyne B, Bonnier HJ, Bartunek J, Wijns W, Peels K, Heyndrickx GR, Koolen JJ, Pijls NH. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol 1998; 31: 841847.
  • 52
    Chamuleau S, Meuwissen M, Koch K, van Eck-Smit B, Tio R, Tijssen J, Piek J. Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. Am J Cardiol 2002; 89: 377380.
  • 53
    Verna E, Lattanzio M, Ghiringhelli S, Provasoli S, Caico SI. Performing versus deferring coronary angioplasty based on functional evaluation of vessel stenosis by pressure measurements: A clinical outcome study. J Cardiovasc Med (Hagerstown) 2006; 7: 169175.
  • 54
    Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar M. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation 2004; 110: 28312836.
  • 55
    Legutko J, Dudek D, Rzeszutko L, Wizimirski M, Dubiel JS. Fractional flow reserve assessment to determine the indications for myocardial revascularisation in patients with borderline stenosis of the left main coronary artery. Kardiol Pol 2005; 63: 499506.
  • 56
    Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G, Nelis O, Bartunek J, Vanderheyden M, Wyffels E, Barbato E, Heyndrickx G, Wijns W, De Bruyne B. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation 2009; 120: 15051512.
  • 57
    Takagi A, Tsurumi Y, Ishii Y, Suzuki K, Kawana M, Kasanuki H. Clinical potential of intravascular ultrasound for physiological assessment of coronary stenosis: Relationship between quantitative ultrasound tomography and pressure-derived fractional flow reserve. Circulation 1999; 100: 250255.
  • 58
    Briguori C, Anzuini A, Airoldi F, Gimelli G, Nishida T, Adamian M, Corvaja N, Di Mario C, Colombo A. Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. Am J Cardiol 2001; 87: 136141.
  • 59
    Nishioka T, Amanullah AM, Luo H, Berglund H, Kim CJ, Nagai T, Hakamata N, Katsushika S, Uehata A, Takase B, Isojima K, Berman DS, Siegel RJ. Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: Comparison with stress myocardial perfusion imaging. J Am Coll Cardiol 1999; 33: 18701878.
  • 60
    Abizaid AS, Mintz GS, Mehran R, Abizaid A, Lansky AJ, Pichard AD, Satler LF, Wu H, Pappas C, Kent KM, Leon MB. Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: Importance of lumen dimensions. Circulation 1999; 100: 256261.
  • 61
    Nam CW, Yoon HJ, Cho YK, Park HS, Kim H, Hur SH, Kim YN, Chung IS, Koo BK, Tahk SJ, Fearon WF, Kim KB. Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: Fractional flow reserve-guided versus intravascular ultrasound-guided. JACC Cardiovasc Interv 2010; 3: 812817.
  • 62
    Ong ATL, Serruys PW. Complete revascularization. Coronary artery bypass graft surgery versus percutaneous coronary intervention. Circulation 2006; 114: 249255.
  • 63
    Serruys PW, Unger F, Souse JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA. Comparison of coronary artery bypass surgery and stenting for the treatment of multi-vessel disease. N Engl J Med 2001; 344: 11171124.
  • 64
    Ijsselmuiden AJJ, Ezechiels JP, Westendorp ICD, Tijssen JGP, Kiemeneij F, Slagboom T, van der Wieken R, Tangelder GJ, Serruys PW, Laaman GJ. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: A randomized comparison. Am Heart J 2004; 148: 467474.
  • 65
    Tamburino C, Angiolillo DJ, Capranzano P, Dimopoulos K, La Manna A, Barbagallo R, Tagliareni F, Mangiafico S, Guzman LA, Galassi AR, Bass TA. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents. Cathet Cardiovasc Intervent 2008; 72: 448456.
  • 66
    Van den Brand MJBM, Rensing BJWM, Morel M-AM, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MMP, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002; 39: 559564.
  • 67
    Hannan EL, Racz M, Holmes DR, King SB, Walford G, Ambrose JA, Sharma S, Katz S, Clark LT, Jones RH. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006; 113: 24062412.
  • 68
    Shishehbor MH, Lauer MS, Singh IM, Chew DP, Karha J, Brener SJ, Moliterno DJ, Ellis SG, Topol EJ, Bhatt DL. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol 2007; 49: 849854.
  • 69
    Kong JA, Chou ET, Minutello RM, Wong SC, Hong MK. Safety of single versus multi-vessel angioplasty for patients with acute myocardial infarction and multi-vessel coronary artery disease: Report from the New York state angioplasty registry. Coron Artery Dis 2006; 17: 7175.
  • 70
    Kalarus Z, Lenarczyk R, Kowalczyk J, Kowalski O, Gasior M, Was T, Zebik T, Krupa H, Chodor P, Polonski L, Zembala M. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am Heart J 2007; 153: 304312.
  • 71
    Srinivas VS, Selzer F, Wilensky RL, Holmes DR, Cohen HA, Monrad ES, Jacobs AK, Kelsey SF, Williams DO, Kip KE. Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: A report from the NHLBI dynamic registry. J Interv Cardiol 2007; 20: 373380.
  • 72
    Bourassa MG, Yeh W, Holubkov R, Sopko G, Detre KM. Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA. A report from the NHLBI PTCA registry. Eur Heart J 1998; 19: 103111.
  • 73
    Mariani G, De Servi S, Dellavalle A, Repetto S, Chierchia S, D'Urbano M, Repetto A, Klersy C, ROSAI Study Group. Complete or incomplete percutaneous coronary revascularization in patients with unstable angina in stent era: Are early and one-year results different? Catheter Cardiovasc Interv 2001; 54: 448453.
  • 74
    McLellan CS, Ghali WA, Labinaz M, Davis RB, Galbraith D, Southern DA, Shrive FM, Knudtson ML for the APPROACH Investigators. Association between completeness of percutaneous coronary revascularization and postprocedure outcomes. Am Heart J 2005; 150: 800806.
  • 75
    Bell MR, Bailey KR, Reeder GS, Lapeyre AC 3rd, Holmes DR Jr. Percutaneous transluminal angioplasty in patients with multivessel coronary disease: How important is complete revascularization for cardiac event-free survival? J Am Coll Cardiol 1990; 16: 553562.
  • 76
    Bourassa MG, Kip KE, Jacobs AK, Jones RH, Sopko G, Rosen AD, Sharaf BL, Schwartz L, Chaitman BR, Alderman EL, Holmes DR, Roubin GS, Detre KM, Frye RL. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 1999; 33: 16271636.
  • 77
    Kloeter UC, Jander NG, Buser PT, Osswald S, Mueller-Brand J, Pfisterer ME. Long-term outcome of angioplasty for multivessel coronary disease: Importance and price of complete revascularization. Int J Cardiol 2001; 79: 197205.
  • 78
    Brener SJ, Murphy SA, Gibson CM, DiBattiste PM, Demopoulos LA, Cannon CP. Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes. Am J Cardiol 2002; 90: 631633.
  • 79
    Nikolsky E, Gruberg L, Patil CV, Roguin A, Kapeliovich M, Petcherski S, Boulos M, Grenadier E, Amikam S, Linn S, Markiewicz W, Beyar R. Percutaneous coronary interventions in diabetic patients: Is complete revascularization important? J Invasive Cardiol 2004; 16: 102106.
  • 80
    Palmer ND, Causer JP, Ramsdale DR, Perry RA. Effect of completeness of revascularization on clinical outcome in patients with multivessel disease presenting with unstable angina who undergo percutaneous coronary intervention. J Invasive Cardiol 2004; 16: 185188.
  • 81
    Varani E, Balducelli M, Aquilina M, Vecchi G, Hussien MN, Frassineti V, Maresta A. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Cathet Cardiovasc Intervent 2008; 72: 927933.
  • 82
    Qarawani D, Nahir M, Abboud M, Hazanov Y, Hasin Y. Culprit only versus complete coronary revascularization during primary PCI. Int J Cardiol 2008; 123: 288292.
  • 83
    Hannan EL, Wu C, Walford G, Holmes DR, Jones RH, Sharma S, King SB 3rd., Incomplete revascularization in the era of drug-eluting stents: Impact on adverse outcomes. JACC Cardiovasc Interv 2009; 2: 1725.
  • 84
    Yang HH, Chen Y, Gao CY. The influence of complete coronary revascularization on long-term outcomes in patients with multivessel coronary heart disease undergoing successful percutaneous coronary intervention. J Int Med Res 2010; 38: 11061112.
  • 85
    Politi L, Sgura F, Rossi R, Monopoli D, Guerri E, Leuzzi C, Bursi F, Sangiorgi GM, Modena MG. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: Major adverse cardiac events during long-term follow-up. Heart 2010; 96: 662667.
  • 86
    Wenawesar P, Surmely J-F, Windecker S, Roffi M, Togni M, Billinger M, Cook S, Vogel R, Seiler C, Hess OM, Meier B. Prognostic value of early exercise testing after coronary stent implantation. Am J Cardiol 2008; 101: 807811.
  • 87
    Breisblatt WM, Barnes JV, Weiland F, Spaccavento LJ. Incomplete revascularization in multivessel percutaneous transluminal coronary angioplasty: The role for stress thallium-201 imaging. J Am Coll Cardiol 1988; 11: 11831190.
  • 88
    Nallamothu B, Krumholz HM. Putting ad hoc PCI on pause. JAMA 2010; 304: 20592060.
  • 89
    Blankenship JC, Klein LW, Laskey WK, Krone RJ, Dehmer GJ, Chambers C, Cowley M. SCAI statement on ad hoc versus the separate performance of diagnostic cardiac catheterization and coronary intervention. Catheter Cardiovasc Interv 2004; 63: 444451.
  • 90
    Fraker TD Jr, Fihn SD; Writing on Behalf of the 2002 Chronic Stable Angina Writing Committee. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: A report of the American college of cardiology/American heart association task force on practice guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 2007; 50: 22642274.
  • 91
    Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE II, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: Executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial Infarction). Circulation 2007; 116: 803877.
  • 92
    Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: Executive summary: A report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction). Circulation 2004; 110: 588636.
  • 93
    Cavendar MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS, Rao SV. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the National Cardiovascular Data Registry). Am J Cardiol 2009; 104: 507513.
  • 94
    Corpus RA, House JA, Marso SP, Grantham JA, Huber KC, Laster SB, Johnson WL, Daniels WC, Barth CW, Giorgi LV, Rutherford BD, Di Mario C, Sansa M, Flavio A, Imad S, Manari A, Petronio A, Piccaluga E, De Servi S, Ramondo A, Colusso S, Formosa A, Cernigliaro C, Colombo A. Single vs multivessel treatment during primary angioplasty: Results of the multicentre randomized HEpacoat for cuLPrit or multivessel stenting for acute myocardial infarction (HELP AMI) study. Int J Cardiovasc Interv 2004; 2–4: 128133.
  • 95
    Qarawani D, Nahir M, Abboud M, Hazanov Y, Hasin Y. Culprit only versus complete revascularization during primary PCI. Int J Cardiol 2008; 123: 288292.
  • 96
    Khattab AA, Abdel-Wahab M, Rother C, Liska B, Toelg R, Kassner G, Geist V, Richardt G. Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. Clin Res Cardiol 2008; 97: 3238.
  • 97
    Varani E, Balducelli M, Aquilina M, Vecchi G, Hussien MN, Frassineti V, Maresta A. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Cathet Cardiovaasc Intervent 2008; 72: 927933.
  • 98
    Yoshitomi Y, Kuramochi M, Kojima S. Acute myocardial infarction with simultaneous occlusions of two major coronary arteries in a young man. Clin Cardiol 1998; 21: 140142.
  • 99
    Shen AY-J, Mansukhani PW, Aharonian VJ, Jorgensen MB. Primary angioplasty for acute myocardial infarction resulting from the simultaneous occlusion of two major coronary arteries. Cathet Cardiovasc Diagn 1999; 47: 203207.
  • 100
    Ntalianis A, Sels JW, Davidavicius G, Tanaka N, Muller O, Trana C, Barbato E, Hamilos M, Mangiacapra F, Heyndrickx GR, Wijns W, Pijls NH, De Bruyne B. Fractional flow reserve for the assessment of nonculprit coronary rrtery stenoses in patients With acute myocardial infarction. JACC Cardiovasc Interv 2010; 3: 12741281.
  • 101
    Webb JG, Lowe AM, Sanborn TA, White HD, Sleeper LA, Carere RG, Buller CE, Wong SC, Boland J, Dzavik V, Porway M, Pate G, Bergman G, Hochman JS; for the SHOCK Investigators. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 2003; 42: 13801386.
  • 102
    Hochman JS. Cardiogenic shock complicating acute myocardial infarction: Expanding the paradigm. Circulation 2003; 107: 29983002.
  • 103
    Reynolds HR, Hochman JS. Cardiogenic shock: Current concepts and improving outcomes. Circulation 2008; 117; 686697.
  • 104
    Rioufol G, Finet G, Ginon I, André-Fouët X, Rossi R, Vialle E, Desjoyaux E, Convert G, Huret JF, Tabib A. Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation 2002; 106: 804808.
  • 105
    Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005; 95: 1319.
  • 106
    Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco C, Eagle KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 10681073.
  • 107
    McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368375.
  • 108
    Brar SS, Shen AY-J, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N, Ree M, Shah AI, Burchette RJ. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography. JAMA 2008; 300: 10381046.
  • 109
    Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93: 15151519.
  • 110
    Klein LW, Sheldon MW, Brinker J, et al. The use of radiographic contrast media during PCI: A focused review. Catheter Cardiovasc Interv 2009; 74: 728746.
  • 111
    Hirshfeld JW Jr, Balter S, Brinker JA, Kern MJ, Klein LW, Lindsay BD, Tommaso CL, Tracy CM, Wagner LK, Creager MA, Elnicki M, Lorell BH, Rodgers GP, Weitz HH. ACCF/AHA/HRS/SCAI clinical competence statement on physician knowledge to optimize patient safety and image quality in fluoroscopically guided invasive cardiovascular procedures. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol 2004; 11: 22592282.
  • 112
    Balter S, Hopewell JW, Miller DL, Wagner LK, Zelefsky MJ. Fluoroscopically guided interventional procedures: A review of radiation effects on patient's skin and hair. Radiology 2010; 257: 15271315.
  • 113
    Chambers CE, Fetterly KA, Holzer R, Pei-Jan PL, Blankenship JC, Balter S, Laskey WK. Radiation safety program for the cardiac catheterization laboratory. Cathet Cardiovasc Intervent 2011; 77: 546556.
  • 114
    Stecker MS, Balter S, Towbin RB, Miller DL, Vano E, Bartal G, Angle F, Chao CP, Cohen AM, Dixon RG, Gross K, Hartnell GG, Scheuler B, Statler JD, de Baere T, Cardella JF. Guidelines for patient radiation management. J Vasc Interv Radiol 2009; 20: S263S273.
  • 115
    Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. Radiation dose to patients from cardiac diagnostic imaging procedures. Circulation 2007; 116: 12901305.
  • 116
    Brueck M, Bandorski D, Kramer W, Holtgen R, Tillmanns. A randomized comparison of transradial versus transfemoral approach for coronary angiography and angioplasty. JACC Cardiovasc Interv 2009; 2: 10471054.
  • 117
    Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials. Am Heart J 2009; 157: 132140.
  • 118
    Pristipino C, Trani C, Nazzaro MS, Berni A, Patti G, Patrizi R, Pironi B, Mazzarotto P, Gioffrè G, Biondi-Zoccai GG, Richichi G; PREVAIL (Prospective Registry of Vascular Access in Interventions in Lazio Region). Prospective registry of vascular access in interventions in lazio region study group. Major improvement of percutaneous cardiovascular procedure. Heart 2009; 95; 476482.
  • 119
    Rao SV, Cohen MG, Kandzari DE, Bertrand OF, Gilchrist IC. The transradial approach to percutaneous coronary intervention. J Am Coll Cardiol 2010; 55: 21872195.
  • 120
    Singh M, Rihal CS, Lennon RJ, Garratt KN, Holmes DR. A critical appraisal of current models of risk stratification for percutaneous coronary interventions. Am Heart J 2005; 149: 753760.
  • 121
    Brindis R, Goldberg SD, Turco MA, Dean LS. President's page: Quality and appropriateness of care: The response to allegations and actions needed by the cardiovascular professional. J Am Coll Cardiol 2011; 57: 111113.